Medplus Health Services Limited — Financials & Forensics
Sector: Consumer Services · NSE: MEDPLUS · BSE: 543427 · ISIN: INE804L01022
18 Aug 2026
Add MEDPLUS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹3,779 Cr | ₹4,558 Cr | ₹5,625 Cr | ₹713 Cr | ₹6,892 Cr |
| EBITDA | ₹272 Cr | ₹266 Cr | ₹354 Cr | ₹78 Cr | ₹607 Cr |
| EBITDA margin | 7.2% | 5.8% | 6.3% | 10.9% | 8.8% |
| Profit after tax | ₹95 Cr | ₹50 Cr | ₹66 Cr | ₹40 Cr | ₹220 Cr |
Deeper analysis
Recent filings by Medplus Health Services Limited
-
BRSR for F.Y. 2025-26
23 Jul 2026 · Regulatory Compliance
-
Notice of 20th AGM of the Company for the F.Y.2025-26
23 Jul 2026 · Corporate Action
-
20th Annual Report of the Company for the Financial Year 2025-26 along with Notice to the Shareholde
23 Jul 2026 · Corporate Action
-
Outcome of the Board meeting
23 Jul 2026 · Board Meeting
-
General Updates
22 Jul 2026 · General Update
Never miss a filing again
About Medplus Health Services Limited on Indian Stock Alerts
Indian Stock Alerts tracks Medplus Health Services Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.